BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Central Standard Time BEGIN:STANDARD DTSTART:20251102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Central Standard Time TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:20250301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Central Daylight Time TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Patients\, caregivers\, and family members are invited to join United Therapeutics and the Pulmonary Fibrosis Foundation (PFF) for an ind ustry hosted webinar at 1:30 p.m. CT on Wednesday\, December 13. This pres entation will focus on how a patient is diagnosed with pulmonary hypertens ion associated with interstitial lung disease (PH-ILD). Presenters will di scuss the tests that are performed at diagnosis.This is the second webinar in the Industry Hosted webinar series. Even if you were unable to join th e first webinar on October 31\, which defined PH-ILD\, discussed how ILD p rogresses to PH-ILD\, and reviewed symptoms of PH-ILD that patients may ex perience\, we encourage you to attend this webinar!Register here!Presented by:Dr. Hyun KimDirector of the Interstitial Lung Disease Program and Asso ciate Professor of Medicine at the University of Minnesota Medical School& nbsp\;Dr. \;Thenappan ThenappanAssociate Professor of Medicine\, Cardi ology at the University of Minnesota Medical SchoolModerated by: Dr. Amy H ajari CaseSenior Medical Advisor of Education and Awareness at the PFF and Director of the Interstitial Lung Disease Program and Pulmonary and Criti cal Care Research Department at Piedmont HealthcareThis Industry Hosted We binar is supported by United Therapeutics. Opinions expressed and resource s shared may not have been reviewed by the PFF before distribution through PFF channels\, or reflect official positions of the PFF unless it is expl icitly noted as a result of official PFF approval. References to specific commercial entities (companies) or products do not reflect review or endor sement by the PFF unless it is explicitly noted as a result of official PF F approval. \; DTEND:20231213T203000Z DTSTAMP:20260313T101848Z DTSTART:20231213T193000Z LOCATION: SEQUENCE:0 SUMMARY:How is PH-ILD Diagnosed? | Industry Hosted Webinar UID:RFCALITEM639089759282407764 X-ALT-DESC;FMTTYPE=text/html:

Patients\, caregivers\, and family members are invited to join United Therapeutics and the Pulmonary Fibrosis Foundat ion (PFF) for an industry hosted webinar at 1:30 p.m. CT on Wednes day\, December 13. This presentation will focus on how a patient is diagnosed with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Presenters will discuss the tests that are performed at diagnosis.

This is the second webinar in the Industry Hosted webina r series. Even if you were unable to join the first webinar on October 31\ , which defined PH-ILD\, discussed how ILD progresses to PH-ILD\, and revi ewed symptoms of PH-ILD that patients may experience\, we encourage you to attend this webinar!

Register here!

< div>

Presented by:

HyunKim_VAM_2022_1

Dr. Hyun Kim
< /strong>Director of the Interstitial Lung Disease Program and Associate Pr ofessor of Medicine at the University of Minnesota Medical School

&n bsp\;

Thenappan Thenappan

Dr.& nbsp\;Thenappan Thenappan
Associate Professor of Medicine\, Cardiology at the Univers ity of Minnesota Medical School

Moderated by: Dr. Amy Hajari Case
Senior Medical Advisor of Education and Awareness at the PFF and Director of the Interstitial Lung Disease Program and Pulmonary a nd Critical Care Research Department at Piedmont Healthcare

This Industry Hosted Webinar is supported by United Therapeut ics. Opinions expressed and resources shared may not have been reviewed by the PFF before distribution through PFF channels\, or reflect official po sitions of the PFF unless it is explicitly noted as a result of official P FF approval. References to specific commercial entities (companies) or pro ducts do not reflect review or endorsement by the PFF unless it is explici tly noted as a result of official PFF approval.

 \;

END:VEVENT END:VCALENDAR